Craig A. Collard - 19 Jan 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
Issuer symbol
HRTX
Transactions as of
19 Jan 2025
Net transactions value
$0
Form type
4
Filing time
22 Jan 2025, 09:06:51 UTC
Previous filing
03 Jan 2025
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +13,797 +4.6% 314,867 19 Jan 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -13,797 -7.7% $0.000000 165,562 19 Jan 2025 Common Stock 13,797 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Includes 10,683 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2024.
F3 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).